
Sign up to save your podcasts
Or


A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.

91,127 Listeners

21,911 Listeners

43,555 Listeners

91 Listeners

6,470 Listeners

113,179 Listeners

5 Listeners

56,962 Listeners

0 Listeners

10,334 Listeners

33 Listeners

3,051 Listeners

8,222 Listeners

29,364 Listeners

1,589 Listeners

4,342 Listeners

7 Listeners

630 Listeners

14,064 Listeners